These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8901962)

  • 21. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhaled nitric oxide therapy].
    Okamoto K; Kukita I; Koga T; Namihira T; Akiyama H
    Nihon Rinsho; 2001 Jun; 59(6):1126-31. PubMed ID: 11411124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Mahajan A; Shabanie A; Varshney SM; Marijic J; Sopher MJ
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):51-6. PubMed ID: 17289480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nitric oxide in the treatment of pulmonary artery hypertension induced by chronic obstructive pulmonary diseases].
    He Q
    Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):565-6. PubMed ID: 9275465
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of nitric oxide administration on pateints with pulmonary hypertension: a dose-response study].
    He J; Cheng X; Xiong C
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):105-6. PubMed ID: 10923418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of inhaled nitric oxide on pulmonary vascular resistance in patients after total cavopulmonary connection].
    Yin ZT; Zhu HY; Zhang RF; Zhang NB; Wang ZW; Gong HD; Wang J; Song HC
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):647-9. PubMed ID: 16008934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hydralazine and oxygen transport in interstitial and chronic obstructive pneumopathies].
    Lupí E; Seoane M; Sandoval J; Martínez W
    Arch Inst Cardiol Mex; 1987; 57(5):357-61. PubMed ID: 2962546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variations in gas exchange and hemodynamic effects of various means of oxygen administration (spontaneous ventilation, controlled ventilation and under I.P.P.B.) in 19 severely obstructed pulmonary hypertension patients].
    Laroche D; Muir JF; Dessirier JL
    Poumon Coeur; 1977; 33(1):63-8. PubMed ID: 327460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of nitric oxide administration by oxygen hood in neonatal pulmonary hypertension.
    Ambalavanan N; St John E; Carlo WA; Bulger A; Philips JB
    J Perinatol; 2002 Jan; 22(1):50-6. PubMed ID: 11840243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report.
    Ramsay MA; Schmidt A; Hein HA; Nguyen AT; Lynch K; East CA; Ramsay KJ; Klintmalm GB
    Hepatology; 1997 Mar; 25(3):524-7. PubMed ID: 9049191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension.
    Chen EP; Bittner HB; Davis RD; Van Trigt P
    Ann Thorac Surg; 1997 Jun; 63(6):1546-55. PubMed ID: 9205146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients.
    Lepore JJ; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    J Heart Lung Transplant; 2005 Nov; 24(11):1950-6. PubMed ID: 16297803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does pulmonary arterial hypertension influence the prognosis in patients with chronic obstructive lung disease?
    Bishop JM
    Cor Vasa; 1985; 27(2-3):172-6. PubMed ID: 4028733
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitric oxide--is there a future?
    Max M; Reyle-Hahn M; Kuhlen R; Dembinski R; Rossaint E
    Acta Anaesthesiol Scand Suppl; 1997; 111():64-8. PubMed ID: 9420958
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of salbutamol on pulmonary circulation, ventilation and gas exchange in patients with chronic obstructive airways disease. Preliminary report.
    Koziorowski A; Zielinski J; Maszczyk Z; Pawlicka L; Klimkiewicz H
    Bull Physiopathol Respir (Nancy); 1972; 8(3):611-6. PubMed ID: 4405131
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of oxygen therapy on pulmonary arterial hypertension in chronic obstructive lung disease.
    Zielinski J
    G Ital Cardiol; 1984; 14 Suppl 1():61-3. PubMed ID: 6398782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inhaled nitric oxide on experimentally induced pulmonary hypertension in neonatal foals.
    Lester GD; DeMarco VG; Norman WM
    Am J Vet Res; 1999 Oct; 60(10):1207-12. PubMed ID: 10791931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of nitric oxide. An innovative therapy for treatment of increased pulmonary vascular resistance.
    Rykerson S; Thompson J; Wessel DL
    Nurs Clin North Am; 1995 Jun; 30(2):381-90. PubMed ID: 7777413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative use of inhaled low-dose nitric oxide.
    Miller OI; James J; Elliott MJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):550-1. PubMed ID: 8445933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.